Olema Pharmaceuticals, Inc.

NASDAQ:OLMA

14.31 (USD) • At close July 19, 2024
Bedrijfsnaam Olema Pharmaceuticals, Inc.
Symbool OLMA
Munteenheid USD
Prijs 14.31
Beurswaarde 800,412,678
Dividendpercentage 0%
52-weken bereik 7.78 - 17.791
Industrie Biotechnology
Sector Healthcare
CEO Dr. Sean P. Bohen M.D., Ph.D.
Website https://www.olema.com

An error occurred while fetching data.

Over Olema Pharmaceuticals, Inc.

Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or

Vergelijkbare Aandelen

Poseida Therapeutics, Inc. logo

Poseida Therapeutics, Inc.

PSTX

3.06 USD

MDxHealth SA logo

MDxHealth SA

MDXH

2.375 USD

MediciNova, Inc. logo

MediciNova, Inc.

MNOV

1.34 USD

Shattuck Labs, Inc. logo

Shattuck Labs, Inc.

STTK

4.4 USD

OncoCyte Corporation logo

OncoCyte Corporation

OCX

3.21 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)